Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 9 | 2024 | 524 | 2.810 |
Why?
|
| RNA | 4 | 2024 | 1030 | 2.140 |
Why?
|
| Sequence Analysis, RNA | 6 | 2024 | 690 | 1.920 |
Why?
|
| Gene Expression Profiling | 8 | 2024 | 5240 | 1.460 |
Why?
|
| Transcriptome | 7 | 2024 | 1952 | 0.960 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 892 | 0.940 |
Why?
|
| Cellular Senescence | 2 | 2024 | 386 | 0.850 |
Why?
|
| Connectome | 1 | 2024 | 116 | 0.800 |
Why?
|
| Transcription Factors | 4 | 2024 | 5362 | 0.670 |
Why?
|
| Cell Cycle | 2 | 2024 | 2115 | 0.660 |
Why?
|
| Synapses | 1 | 2023 | 530 | 0.640 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 374 | 0.530 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2012 | 89 | 0.530 |
Why?
|
| Lysogeny | 2 | 2010 | 11 | 0.470 |
Why?
|
| Synaptosomes | 2 | 2024 | 38 | 0.450 |
Why?
|
| Macrophages | 2 | 2019 | 1372 | 0.400 |
Why?
|
| Hair Cells, Auditory | 2 | 2024 | 63 | 0.390 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2010 | 67 | 0.370 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2017 | 2340 | 0.360 |
Why?
|
| Point Mutation | 1 | 2012 | 774 | 0.350 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 1801 | 0.350 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2010 | 195 | 0.340 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2021 | 114 | 0.330 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 4908 | 0.310 |
Why?
|
| Genomic Instability | 1 | 2010 | 525 | 0.300 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 1929 | 0.290 |
Why?
|
| Glioblastoma | 1 | 2017 | 1844 | 0.280 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1538 | 0.260 |
Why?
|
| Genomics | 1 | 2017 | 2818 | 0.260 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2019 | 623 | 0.250 |
Why?
|
| Genome, Human | 3 | 2021 | 1897 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5234 | 0.220 |
Why?
|
| Deafness | 1 | 2024 | 81 | 0.220 |
Why?
|
| Repressor Proteins | 1 | 2010 | 1699 | 0.210 |
Why?
|
| Kinetics | 2 | 2024 | 2098 | 0.210 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 2980 | 0.210 |
Why?
|
| RNA Splicing | 1 | 2024 | 375 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 2 | 2020 | 1574 | 0.200 |
Why?
|
| Gene Expression Regulation | 3 | 2024 | 4068 | 0.190 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2021 | 43 | 0.190 |
Why?
|
| Bacteriophage lambda | 2 | 2010 | 39 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 4644 | 0.190 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 145 | 0.180 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 159 | 0.180 |
Why?
|
| Escherichia coli | 3 | 2011 | 1221 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2021 | 334 | 0.170 |
Why?
|
| Saccule and Utricle | 1 | 2019 | 11 | 0.170 |
Why?
|
| Reverse Transcription | 1 | 2019 | 8 | 0.170 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 297 | 0.160 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 312 | 0.160 |
Why?
|
| Gene Amplification | 1 | 2021 | 745 | 0.160 |
Why?
|
| Gene Library | 1 | 2019 | 300 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2019 | 276 | 0.150 |
Why?
|
| Animals | 10 | 2024 | 60962 | 0.150 |
Why?
|
| Gene Ontology | 1 | 2017 | 81 | 0.150 |
Why?
|
| Macrophage Activation | 1 | 2017 | 147 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 14852 | 0.150 |
Why?
|
| DNA, Complementary | 1 | 2019 | 880 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 3698 | 0.140 |
Why?
|
| Tamoxifen | 1 | 2021 | 883 | 0.140 |
Why?
|
| Morphogenesis | 1 | 2018 | 344 | 0.140 |
Why?
|
| Aurora Kinases | 1 | 2017 | 194 | 0.140 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 560 | 0.140 |
Why?
|
| Regeneration | 1 | 2019 | 288 | 0.140 |
Why?
|
| Humans | 15 | 2024 | 270701 | 0.130 |
Why?
|
| Mice | 6 | 2023 | 35291 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 2506 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 355 | 0.120 |
Why?
|
| Pancreas | 1 | 2018 | 735 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2021 | 1048 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1377 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2021 | 1848 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2017 | 604 | 0.110 |
Why?
|
| DNA Damage | 1 | 2021 | 1988 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 1512 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 2395 | 0.100 |
Why?
|
| Meiosis | 1 | 2012 | 172 | 0.100 |
Why?
|
| Mutation Rate | 1 | 2012 | 230 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 1059 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 1431 | 0.100 |
Why?
|
| Benzamides | 1 | 2017 | 1873 | 0.100 |
Why?
|
| Cochlea | 2 | 2024 | 106 | 0.100 |
Why?
|
| Computational Biology | 1 | 2017 | 1299 | 0.100 |
Why?
|
| Organisms, Genetically Modified | 1 | 2010 | 14 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 1508 | 0.090 |
Why?
|
| Time | 1 | 2011 | 183 | 0.090 |
Why?
|
| Bacteriolysis | 1 | 2010 | 11 | 0.090 |
Why?
|
| Genes, Viral | 1 | 2010 | 201 | 0.090 |
Why?
|
| Spermatozoa | 1 | 2012 | 319 | 0.090 |
Why?
|
| Brain | 1 | 2024 | 4192 | 0.090 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 623 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2010 | 205 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2019 | 1295 | 0.080 |
Why?
|
| Cell Line | 1 | 2017 | 5128 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3288 | 0.080 |
Why?
|
| Pyrazoles | 1 | 2017 | 1519 | 0.080 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 3107 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 7962 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2019 | 3481 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2652 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 3148 | 0.050 |
Why?
|
| Neoplasms | 2 | 2020 | 15705 | 0.050 |
Why?
|
| Mammals | 1 | 2024 | 372 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 3254 | 0.050 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2021 | 18 | 0.050 |
Why?
|
| Alpha-Globulins | 1 | 2021 | 14 | 0.050 |
Why?
|
| Discoidin Domain Receptor 2 | 1 | 2021 | 10 | 0.050 |
Why?
|
| Epithelium | 1 | 2024 | 729 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 4893 | 0.050 |
Why?
|
| Granulocytes | 1 | 2019 | 226 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2021 | 797 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 106 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 11817 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 506 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 243 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 468 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 1798 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 700 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 7156 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 115 | 0.040 |
Why?
|
| Cell Death | 1 | 2019 | 675 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 2017 | 118 | 0.030 |
Why?
|
| Fibrosis | 1 | 2020 | 805 | 0.030 |
Why?
|
| Pericytes | 1 | 2017 | 97 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2020 | 831 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2018 | 1059 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 335 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 194 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2020 | 702 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 259 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 214 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 1141 | 0.030 |
Why?
|
| Morpholines | 1 | 2017 | 293 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2021 | 991 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 7420 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 845 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 2480 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 445 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 9066 | 0.030 |
Why?
|
| Pyridones | 1 | 2017 | 366 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 14505 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 7908 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 505 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 2498 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2012 | 51 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4230 | 0.030 |
Why?
|
| Crossing Over, Genetic | 1 | 2012 | 58 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2017 | 1162 | 0.030 |
Why?
|
| Chromosome Segregation | 1 | 2012 | 83 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 12138 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 2403 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 1513 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1007 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3071 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 291 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2012 | 373 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 1243 | 0.020 |
Why?
|
| Cytokines | 1 | 2020 | 2867 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2017 | 1076 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 883 | 0.020 |
Why?
|
| Female | 5 | 2019 | 147234 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 1043 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2010 | 120 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 3593 | 0.020 |
Why?
|
| Disease Progression | 1 | 2020 | 6888 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 7300 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3930 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 839 | 0.020 |
Why?
|
| Male | 4 | 2021 | 127579 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2021 | 2955 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2018 | 4163 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2260 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7823 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 6222 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 22243 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 80680 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 89506 | 0.000 |
Why?
|